Investor and Analyst Day to be held in Boston on December 10 at 10:30 am. LGND)pharmaceuticals/’ target= ‘_blank’; rel=’nofollow’>Webcast Link Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks on TipRanks >> Read More on LGND: Ligand price target raised to $141 from $140 at RBC Capital Ligand price target raised to $147 from $135 at Oppenheimer Ligand price target raised to $150 from $125 at Barclays Ligand Pharmaceuticals Reports Strong Q3 2024 Growth Ligand reports Q3 EPS $1.84, consensus $1.35
